Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Germains expands PHC harpin tests

The UK seed treatment company, Germains Seed Technology (King’s Lynn, Norfolk), is to carry out large-scale US field trials with US-based, UK-listed bioproducts company Plant Health Care’s (PHC – Pittsburgh, Pennsylvania) Harpinαβ as a sugar beet seed treatment this year. The companies agreed a development deal for the technology in 2010 ( Agrow No 601, p 2). The decision to move to the next stage of testing triggers a milestone payment to PHC. “This is a very positive development in our relationship with Germains and gives us further confidence in the potential of our Harpinαβ protein products,” says PHC chief executive officer John Brady. Harpin proteins induce disease resistance and reduce nematode numbers around treated plants. PHC is developing the technology as a seed and foliar treatment with several partners ( Agrow No 653, pp 11-12).



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts